The book will be published by Random House and their press release says it will be "open, candid and intimate" and will tell Yuvraj's journey through cancer "from denial and acceptance, from his battle to defeat the disease to the struggles he still faces".
This is nothing new, as Bayer has been funding cancer research for many years as part of an expressed corporate mission to develop drugs to defeat the disease.